FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Jun 16, 2017
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on June 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0dc5ed23-04e8-408c-811f-a18647f3e1b5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015874
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla Limited
13| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| June 21, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cipla Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.